VXRT – Vaxart, Inc.
VXRT
$0.4053Name : Vaxart, Inc. - Common Stock
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $92,498,784.00
EPSttm : -0.26
Vaxart, Inc. - Common Stock
$0.4053
Float Short %
6.46
Margin Of Safety %
Put/Call OI Ratio
0.05
EPS Next Q Diff
0.01
EPS Last/This Y
0.04
EPS This/Next Y
-0.05
Price
0.4
Target Price
4.67
Analyst Recom
1
Performance Q
-13.73
Relative Volume
0.43
Beta
1.15
Ticker: VXRT
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-05-08 | VXRT | 0.4031 | 0.06 | 0.12 | 9084 |
2025-05-09 | VXRT | 0.4198 | 0.06 | 0.11 | 9089 |
2025-05-12 | VXRT | 0.4062 | 0.06 | 0.00 | 9176 |
2025-05-13 | VXRT | 0.4105 | 0.06 | 0.00 | 9212 |
2025-05-14 | VXRT | 0.4087 | 0.06 | 0.00 | 9811 |
2025-05-15 | VXRT | 0.421 | 0.05 | 0.04 | 10187 |
2025-05-16 | VXRT | 0.5099 | 0.05 | 0.01 | 10270 |
2025-05-19 | VXRT | 0.4938 | 0.05 | 0.03 | 9837 |
2025-05-20 | VXRT | 0.5073 | 0.05 | 0.03 | 9983 |
2025-05-21 | VXRT | 0.4575 | 0.05 | 0.01 | 10145 |
2025-05-22 | VXRT | 0.466 | 0.05 | 0.11 | 10249 |
2025-05-23 | VXRT | 0.4634 | 0.06 | 0.05 | 10290 |
2025-05-27 | VXRT | 0.46 | 0.06 | 0.04 | 10350 |
2025-05-28 | VXRT | 0.45 | 0.06 | 0.02 | 10421 |
2025-05-29 | VXRT | 0.4623 | 0.06 | 0.05 | 10526 |
2025-05-30 | VXRT | 0.4331 | 0.06 | 0.02 | 10670 |
2025-06-02 | VXRT | 0.448 | 0.05 | 0.00 | 10975 |
2025-06-03 | VXRT | 0.4161 | 0.05 | 0.82 | 11023 |
2025-06-04 | VXRT | 0.4014 | 0.05 | 0.05 | 11001 |
2025-06-05 | VXRT | 0.3944 | 0.05 | 0.19 | 11303 |
2025-06-06 | VXRT | 0.405 | 0.05 | 0.25 | 11426 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-05-08 | VXRT | 0.40 | 50.0 | - | -0.34 |
2025-05-09 | VXRT | 0.42 | 50.0 | - | -0.34 |
2025-05-12 | VXRT | 0.41 | 50.0 | - | -0.34 |
2025-05-13 | VXRT | 0.42 | 50.0 | - | -0.34 |
2025-05-14 | VXRT | 0.41 | 50.0 | - | -0.34 |
2025-05-15 | VXRT | 0.42 | 50.0 | - | -0.34 |
2025-05-16 | VXRT | 0.51 | 50.0 | - | -0.34 |
2025-05-19 | VXRT | 0.50 | -22.2 | - | -0.34 |
2025-05-20 | VXRT | 0.51 | -22.2 | - | -0.34 |
2025-05-21 | VXRT | 0.46 | -22.2 | - | -0.34 |
2025-05-22 | VXRT | 0.46 | -22.2 | - | -0.34 |
2025-05-23 | VXRT | 0.46 | -22.2 | - | -0.34 |
2025-05-27 | VXRT | 0.46 | -22.2 | - | -0.34 |
2025-05-28 | VXRT | 0.45 | -22.2 | - | -0.34 |
2025-05-29 | VXRT | 0.46 | -22.2 | - | -0.34 |
2025-05-30 | VXRT | 0.43 | -22.2 | - | -0.34 |
2025-06-02 | VXRT | 0.45 | -22.2 | - | -0.29 |
2025-06-03 | VXRT | 0.42 | -5.6 | - | -0.29 |
2025-06-04 | VXRT | 0.40 | -5.6 | - | -0.29 |
2025-06-05 | VXRT | 0.40 | -5.6 | - | -0.29 |
2025-06-06 | VXRT | 0.40 | -5.6 | - | -0.29 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-05-08 | VXRT | 0.00 | -16.09 | 5.91 |
2025-05-09 | VXRT | 0.00 | -16.09 | 5.91 |
2025-05-12 | VXRT | 0.00 | -17.15 | 5.41 |
2025-05-13 | VXRT | 0.00 | -17.15 | 5.41 |
2025-05-14 | VXRT | 0.00 | -17.15 | 5.41 |
2025-05-15 | VXRT | 0.00 | -17.15 | 5.41 |
2025-05-16 | VXRT | 0.00 | -17.15 | 5.41 |
2025-05-19 | VXRT | 0.00 | -15.47 | 5.41 |
2025-05-20 | VXRT | 1.81 | -15.47 | 5.41 |
2025-05-21 | VXRT | 1.81 | -15.47 | 5.41 |
2025-05-22 | VXRT | 1.81 | -15.47 | 5.41 |
2025-05-23 | VXRT | 1.81 | -15.47 | 5.41 |
2025-05-27 | VXRT | 1.67 | -23.52 | 5.43 |
2025-05-28 | VXRT | 1.67 | -23.52 | 6.46 |
2025-05-29 | VXRT | 1.67 | -23.52 | 6.46 |
2025-05-30 | VXRT | 1.67 | -23.52 | 6.46 |
2025-06-02 | VXRT | 1.67 | -23.52 | 6.46 |
2025-06-03 | VXRT | 1.67 | -23.52 | 6.46 |
2025-06-04 | VXRT | 1.67 | -23.52 | 6.46 |
2025-06-05 | VXRT | 1.67 | -23.52 | 6.46 |
2025-06-06 | VXRT | 1.67 | -23.52 | 6.46 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.07
Avg. EPS Est. Current Quarter
-0.1
Avg. EPS Est. Next Quarter
-0.07
Insider Transactions
1.67
Institutional Transactions
-23.52
Beta
1.15
Average Sales Estimate Current Quarter
2
Average Sales Estimate Next Quarter
2
Fair Value
Quality Score
24
Growth Score
39
Sentiment Score
2
Actual DrawDown %
98.4
Max Drawdown 5-Year %
-98.7
Target Price
4.67
P/E
Forward P/E
PEG
P/S
1.95
P/B
2.03
P/Free Cash Flow
EPS
-0.27
Average EPS Est. Cur. Y
-0.29
EPS Next Y. (Est.)
-0.34
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-122.63
Relative Volume
0.43
Return on Equity vs Sector %
-151.5
Return on Equity vs Industry %
-133.5
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.05
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 105
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
stock quote shares VXRT – Vaxart, Inc. Stock Price stock today
news today VXRT – Vaxart, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VXRT – Vaxart, Inc. yahoo finance google finance
stock history VXRT – Vaxart, Inc. invest stock market
stock prices VXRT premarket after hours
ticker VXRT fair value insiders trading